Mark Abrams, MD
Clinical Cardiac Electrophysiology · Mount Kisco, NYNPI 1063755213
Payments from drug & device makers
Across 234 payments — averaging $129.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$14K
- Boston Scientific$9K
- Abbott$6K
- Biosense Webster, Inc.$387
- Philips North America LLC$138
- Irhythm Technologies, Inc.$68
- plus $72 from 4 others
What the payments were for
- Grants$24,54681%
- Food & beverage$5,44218%
- Education$3901%
- Other$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 63 | $14,074 |
| Boston Scientific | 98 | $9,346 |
| Abbott | 63 | $6,306 |
| Biosense Webster, Inc. | 3 | $387 |
| Philips North America LLC | 2 | $138 |
| Irhythm Technologies, Inc. | 1 | $68 |
| Astellas Pharma US Inc | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $19 |
| AstraZeneca | 1 | $17 |
| Baxter Healthcare | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$7,500
- Carto 3$387
- GENERAL - THERAPIES$266
- Micra$261
- EnSite Precision Cardiac Mapping System$238
- Assurity Pacemaker$202
- Reveal LINQ$166
- Soundstar$153
- Ensite Cardiac Mapping System$152
- AMPLATZER Occluders$138
- GlideLight$134
- Quadra Assura CRT Defibrillator$127
- LATITUDE$126
- AFFERA MAPPING SYSTEM$125
- Abre$121
- Navistar$118
- DecaNav$116
- ACUITY$113
How this compares
$30,390 in reported general payments places this provider in the 50th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 203 | $205,727 |
| XareltoRivaroxaban | 60 | $63,734 |
| MultaqDronedarone Hcl | 25 | $24,241 |
| Metoprolol Succinate | 144 | $2,459 |
| Amiodarone Hcl | 21 | $587 |
| Digoxin | 16 | $354 |
| Atorvastatin Calcium | 11 | $219 |
| SotalolSotalol Hcl | 15 | $209 |
| Losartan Potassium | 12 | $128 |
| Metoprolol Tartrate | 25 | $53 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Mount Kisco
- Vivek ReddyNew York$16.7M
- Srinivas DukkipatiNew York$4.2M
- Jacob KoruthNew York$4M
- Stavros MountantonakisManhasset$2.6M
- Jorge RomeroSyracuse$2.6M
- Larry ChinitzNew York$2.6M
- David HuangRochester$2.2M
- James IpNew York$1.2M
- Jonathan WillnerStaten Island$1.2M
- Christopher LiuNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.